BIO-key International, Inc. develops and markets fingerprint biometric identification and identity verification technologies, and related identity management and credentialing biometric hardware and software solutions.
+ 2 more risks
Mediocre balance sheet with limited growth.
Share Price & News
How has BIO-key International's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: BKYI's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: BKYI underperformed the US Software industry which returned 35.1% over the past year.
Return vs Market: BKYI underperformed the US Market which returned 17.8% over the past year.
Price Volatility Vs. Market
How volatile is BIO-key International's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall StThose Who Purchased BIO-key International (NASDAQ:BKYI) Shares Three Years Ago Have A 74% Loss To Show For It
3 weeks ago | Simply Wall StIs BIO-key International, Inc. (NASDAQ:BKYI) Excessively Paying Its CEO?
1 month ago | Simply Wall StBIO-key International (NASDAQ:BKYI) Is Carrying A Fair Bit Of Debt
Is BIO-key International undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate BKYI's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate BKYI's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: BKYI is unprofitable, so we can't compare its PE Ratio to the Software industry average.
PE vs Market: BKYI is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate BKYI's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: BKYI is good value based on its PB Ratio (1.5x) compared to the US Software industry average (5.9x).
How is BIO-key International forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BKYI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BKYI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BKYI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BKYI's revenue (36.2% per year) is forecast to grow faster than the US market (7.6% per year).
High Growth Revenue: BKYI's revenue (36.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BKYI's Return on Equity is forecast to be high in 3 years time
How has BIO-key International performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: BKYI is currently unprofitable.
Growing Profit Margin: BKYI is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: BKYI is unprofitable, and losses have increased over the past 5 years at a rate of -28.3% per year.
Accelerating Growth: Unable to compare BKYI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BKYI is unprofitable, making it difficult to compare its past year earnings growth to the Software industry (18.4%).
Return on Equity
High ROE: BKYI has a negative Return on Equity (-90.44%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
How is BIO-key International's financial position?
Financial Position Analysis
Short Term Liabilities: BKYI's short term assets ($3.7M) exceed its short term liabilities ($3.2M).
Long Term Liabilities: BKYI's short term assets ($3.7M) exceed its long term liabilities ($426.9K).
Debt to Equity History and Analysis
Debt Level: BKYI's debt to equity ratio (26.1%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if BKYI's debt to equity ratio has reduced over the past 5 years.
Inventory Level: BKYI has a low level of unsold assets or inventory.
Debt Coverage by Assets: BKYI's debt is covered by short term assets (assets are 2x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BKYI has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BKYI has less than a year of cash runway if free cash flow continues to grow at historical rates of 6.3% each year.
What is BIO-key International's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate BKYI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate BKYI's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if BKYI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BKYI's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of BKYI's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mike DePasquale (64yo)
Mr. Michael W. DePasquale, also known as Mike, has been the Chief Executive Officer of BIO-key International Inc. since August 2006. Mr. DePasquale served as the Chief Executive Officer of BIO-key Internat ...
CEO Compensation Analysis
Compensation vs Market: Mike's total compensation ($USD333.10K) is below average for companies of similar size in the US market ($USD521.92K).
Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.
|Chairman & CEO||17.1yrs||US$333.10k||0.072% $8.0k|
|Chief Financial Officer||10.2yrs||US$218.64k||no data|
|Chief Technology Officer||5.9yrs||US$235.25k||no data|
|Vice President of Marketing||9yrs||US$155.95k||no data|
|Senior Vice President of Strategy & Business Development||7.8yrs||no data||no data|
|Chief Revenue Officer||1.4yrs||no data||no data|
|Managing Director - Africa||0.3yrs||no data||no data|
Experienced Management: BKYI's management team is seasoned and experienced (7.8 years average tenure).
|Chairman & CEO||17.1yrs||US$333.10k||0.072% $8.0k|
|Independent Director||3.8yrs||US$10.59k||0.12% $13.0k|
|Independent Director||6.1yrs||US$9.09k||0.15% $17.0k|
|Independent Director||2.3yrs||US$8.09k||0.068% $7.5k|
|Independent Director||2.8yrs||US$11.09k||0.14% $15.7k|
|Independent Director||6.1yrs||US$9.59k||0.12% $13.5k|
Experienced Board: BKYI's board of directors are considered experienced (4.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 41.3%.
BIO-key International, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: BIO-key International, Inc.
- Ticker: BKYI
- Exchange: NasdaqCM
- Founded: 1993
- Industry: Systems Software
- Sector: Software
- Market Cap: US$11.041m
- Shares outstanding: 14.41m
- Website: https://www.bio-key.com
Number of Employees
- BIO-key International, Inc.
- Building A
- Suite E
- New Jersey
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|BKYI||NasdaqCM (Nasdaq Capital Market)||Yes||Common Stock||US||USD||Feb 1997|
BIO-key International, Inc. develops and markets fingerprint biometric identification and identity verification technologies, and related identity management and credentialing biometric hardware and software solutions. Its solutions enable application developers, value added resellers, and channel partners to integrate fingerprint biometrics into their applications. It offers ID Director, a solution for integration with CA Technologies / Broadcom’s Single Sign-on solution, Oracle’s Fusion Middleware SSO, IBM Tivoli Access Manager, as well as ISAM and other solutions. The company also provides Vector Segment Technology SDK, a biometric software development kit that provides developers the ability to incorporate its biometric capabilities into their respective product offerings or infrastructure; Intelligent Image Indexing, a biometric identification solution that offers one-to-many and one-to-one user identification; and Biometric Service Provider, which provides support for the BioAPI for a compliant interface to applications using biometrics for verification and identification. In addition, it offers WEB-key, an authentication-transaction security technology to conduct identification and identity verification transactions in unsecure environments, such as the world wide Web or off-site cloud environments. Additionally, the company develops and distributes hardware components; and sells third-party hardware components. BIO-key International, Inc. markets its products through its direct sales force, as well as through distributors, resellers, integrators, and partner networks to government and corporate customers primarily in North America. It has strategic partnership with Quantum Business Advisory to bring its software and hardware solutions to enterprises in India. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/24 23:45|
|End of Day Share Price||2020/02/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.